Dutapro Tablet (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 tablet (0.5mg) once daily. Swallow this medicine whole without chewing or splitting it. This medicine may be taken with or without food. No dose adjustment is necessary in patients with renal impairment or older adults. Since there are no data on administration of this medicine to patients with hepatic impairment, the recommended dose for these patients has not been established.

This medication can be absorbed through the skin, so women who are pregnant or may become pregnant should not handle this medication directly. Particular care should be taken to avoid touching broken or shattered pieces of this medication, and if contact occurs, hands should be washed immediately. Children should also be kept from touching broken pieces of this medication, and it should not be administered to children under the age of 18. Women must not take this medication, and it should also not be administered to individuals allergic to this medication or any of its components. Adult men planning to conceive should exercise caution as this medication may affect fertility, and consultation with a physician is essential before considering its use. Patients with large residual urine volumes or severe reductions in urinary flow should be monitored closely as there could be issues such as urinary retention upon taking this medication. Patients with liver dysfunction should be cautious when administering this medication as it may affect hepatic metabolism. Furthermore, when taken with strong CYP3A4 inhibitors, the concentration of this medication in the blood may increase, necessitating careful management when used in combination. While on this medication, side effects related to sexual function such as erectile dysfunction, decreased libido, and ejaculation disorders may occur, and these symptoms may persist even after discontinuation of the medication. Breast-related side effects have also been reported, including breast tenderness or gynecomastia, so any abnormal symptoms should be reported to healthcare professionals. Regular prostate-specific antigen (PSA) tests should be conducted to monitor for prostate cancer risk while taking this medication, and PSA levels may decrease after taking this medication, so this should be considered when interpreting test results. This medication may increase the risk of high-grade prostate cancer with prolonged use, so regular examinations with healthcare professionals are necessary. Patients taking this medication should refrain from donating blood for at least six months after the last dose, to prevent the medication from being transmitted to a pregnant woman. No specific antidote exists for overdose, so if symptoms occur, immediate medical attention should be sought. This medication should be stored out of reach of children, and should be kept in its original container to prevent misuse or degradation of quality. While the likelihood of affecting driving or machinery operation is low, unusual reactions may occur in individuals, so care should be taken. There may be interaction possibilities with other medications, so patients must inform their healthcare provider of any other medications they are taking.

• erectile dysfunction
• reduced libido
• ejaculation disorder
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• rash

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is safest to keep it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy and prevents degradation.

Appearance

Pale yellow oval film-coated tablet

Package unit

30 tablets/PTP [(10 tablets/PTP) x 3]